RBC Adjusts Price Target on Bluebird Bio to $8 From $80 Amid Reverse Stock Split, 'Limited Cash Runway,' Keeps Sector Perform, Speculative Risk

MT NewswiresJan 7 20:38 · Ratings

Analysts Offer Insights on Healthcare Companies: Cencora (COR) and Bluebird Bio (BLUE)

TipRanksJan 7 18:40 · Ratings

Express News | Bluebird bio Inc : Leerink Partners Raises Target Price to $10 From $1

BreakingsJan 3 11:43

Bluebird Bio Analyst Ratings

BenzingaDec 31, 2024 19:02 · Ratings

Barclays Maintains Bluebird Bio(BLUE.US) With Buy Rating, Maintains Target Price $40

Futu NewsDec 31, 2024 11:32 · Ratings

Bluebird Bio, Inc. (BLUE): Is This Gene Therapy Stock a Good Buy Right Now?

Yahoo FinanceDec 29, 2024 19:07